US 11946049
tRNA/pre-miRNA compositions and use in treating cancer
granted A61KA61K31/7105A61K31/713
Quick answer
US patent 11946049 (tRNA/pre-miRNA compositions and use in treating cancer) held by The Regents of the University of California expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7105, A61K31/713, A61K45/06, A61K47/6911